Clinical trial for prostate cancer patients with ED - Topix
Links shared publicly online about this topic.
- 0total visits
Clinical trial for prostate cancer patients with ED - Topix
View full resource at topix.com
Tags: Cancer, Prostate Cancer, Prostate, Clinical Trial, Men's Health
Most Recently Shared on September 23, 2011 at 12:24 am By:
Clinical trial for prostate cancer patients with ED: The West Michigan Cancer Center in Kalamazoo, Michigan, is ... http://t.co/EWLhsA8b
In Patients With Drug-Resistant Prostate Cancer, New Drug Extends Survival
medicalnewstoday.com — “A new drug, MDV3100, is improving the survival rate in men with advanced prostate cancer, results of a large, phase III clinical trial show. The drug is designed to block a type of cellular recept” View full resource at medicalnewstoday.com
Most Recently Shared on February 2, 2012 at 8:05 am By:
In Patients With Drug-Resistant Prostate Cancer, New Drug Extends Survival http://t.co/rocDqfAo #prostate
Researchers target multiple tumors in new cancer vaccine study - FierceVaccines
fiercevaccines.com — “Targeting a variety of tumor types, the Roswell Park Cancer Institute has begun recruiting patients for an early-stage clinical trial to test an experimental cancer vaccine. The vaccine, or Read more...” View full resource at fiercevaccines.com
Most Recently Shared on January 26, 2012 at 2:06 pm By:
RT @FierceBiotech: Future threat to Provenge? New cancer vax study targets multiple tumors (prostate, lung, etc) http://t.co/oCAnW1wj
Cabazitaxel with IMRT, androgen deprivation therapy may extend survival for prostate cancer patients
news-medical.net — “Jefferson's Kimmel Cancer Center has started a Phase I clinical trial investigating the latest prostate cancer chemotherapy drug to extend survival, Cabazitaxel, in combination with radiation and hormone therapy. This first-of-its-kind multimodality approach could improve disease control and eventually survival for locally advanced prostate cancer patients.” View full resource at news-medical.net
Most Recently Shared on January 13, 2012 at 9:28 am By:
john clay mchugh Surgeon, Urologist, Physician, and Doctor
Cabazitaxel with IMRT, androgen deprivation therapy may extend survival for prostate cancer patients: Jefferson'... http://t.co/y7uUj2MD
Soligenix reports results from orBec Phase 2 trial on acute GVHD
news-medical.net — “Soligenix, Inc., a development stage biopharmaceutical company, announced the publication of results from its investigator-initiated Phase 2 "proof-of-concept" exploratory clinical trial of orBec for the prevention of acute Graft-versus-Host disease (GVHD) in patients undergoing myeloablative conditioning regimens with initiation of dosing prior to hematopoietic cell transplantation (HCT) and continuing through the post-transplantation period.” View full resource at news-medical.net
Most Recently Shared on December 12, 2011 at 3:10 pm By:
Prostate Cancer: Soligenix reports results from orBec Phase 2 trial on acute GVHD: Soligenix, Inc., a developmen... http://t.co/rU2LofNZ
Positive initial results from CytRx's INNO-206 Phase 1b/2 clinical trial for advanced solid tumors
news-medical.net — “CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced favorable response and safety indications from a group of patients with advanced solid tumors (principally soft tissue sarcomas) in the Company's ongoing Phase 1b/2 clinical trial with INNO-206, its tumor-targeting conjugate of the commonly used chemotherapeutic agent doxorubicin.” View full resource at news-medical.net
Most Recently Shared on October 31, 2011 at 2:18 pm By:
Lung Cancer News: Positive initial results from CytRx's INNO-206 Phase 1b/2 clinical trial for advanced solid tu... http://t.co/djFEqt79
OncoGenex commences enrollment in OGX-427 Phase II trial for bladder cancer
news-medical.net — “OncoGenex Pharmaceuticals, Inc. announced today that it has initiated patient enrollment in a randomized, Phase II clinical trial evaluating OGX-427, an inhibitor of heat shock protein 27 (Hsp27), in patients with advanced bladder cancer.” View full resource at news-medical.net
Most Recently Shared on October 21, 2011 at 4:41 am By:
OncoGenex commences enrollment in OGX-427 Phase II trial for bladder cancer: OncoGenex Pharmaceuticals, Inc. ann... http://t.co/bhYsjTPo
Abiraterone acetate improves fatigue in prostate cancer patients, says international clinical trial
medicalxpress.com — “Stockholm, Sweden: Men with prostate cancer that has spread to other parts of the body and that is resistant to hormone therapy suffer less from fatigue if they are treated with a combination of abiraterone acetate and prednisone, according to results from a phase III clinical trial presented today.” View full resource at medicalxpress.com
Most Recently Shared on September 25, 2011 at 5:27 pm By:
Abiraterone acetate improves fatigue in prostate cancer patients, says international clinical trial http://t.co/A12lUnu4
Adamis Pharmaceuticals Begins Prostate Cancer Trial | Business Wire
businesswire.com — “Adamis Pharmaceuticals Corporation (OTCBB: ADMP) announced today that it enrolled the first patient in its Phase 1/2a clinical prostate study. Adamis&” View full resource at businesswire.com
Most Recently Shared on August 30, 2011 at 3:38 pm By:
john clay mchugh Surgeon, Urologist, Physician, and Doctor
Adamis Pharmaceuticals Begins Prostate Cancer Trial: SAN DIEGO--(BUSINESS WIRE)--Adamis Pharmaceuticals Corporat... http://t.co/FcucGUg
HIFU Clinical Trials | Dr. Stephen Scionti - HIFU Specialist
drscionti.com — “High Intensity Focused Ultrasound (HIFU) has wide international acceptance as a noninvasive treatment for prostate cancer. In fact, many European centers as well as Asia, Canada, India and Latin American countries have cleared the use of HIFU for prostate cancer as well as for benign uterine fibroid tumors in women.” View full resource at drscionti.com
Most Recently Shared on August 29, 2011 at 11:07 pm By:
Stephen Scionti, MD Physician, Doctor, Surgeon, and Urologist
My book Aiming At Life is 4 prostate cancer patients & their families 2 help determine if cryotherapy is right 4 them http://t.co/7tsX3gf
Post-surgical enrollment in clinical trials by cancer patients « THE "NEW" PROSTATE CANCER INFOLINK
prostatecancerinfolink.net — “Post-surgical enrollment in clinical trials by cancer patients « THE "NEW" PROSTATE CANCER INFOLINK” View full resource at prostatecancerinfolink.net
Most Recently Shared on August 29, 2011 at 3:37 pm By:
john clay mchugh Surgeon, Urologist, Physician, and Doctor
Post-surgical enrollment in clinical trials by cancer patients: The national rates of participation in clinical ... http://t.co/evrvn5y
Urology Article | Prostatic Neoplasms
mdlinx.com — “Sunitinib in combination with docetaxel and prednisone in chemotherapy-naive patients with metastatic, castration-resistant prostate cancer: A phase 1/2 clinical trial” View full resource at mdlinx.com
Most Recently Shared on August 10, 2011 at 12:30 pm By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Sunitinib in combination with docetaxel and prednisone in chemotherapy-naive patients with metastatic, ... http://bit.ly/qfbvaJ #urology
Polaris initiates ADI-PEG 20 Phase 3 trial in hepatocellular carcinoma
news-medical.net — “Polaris Group today announced that it has dosed the first patient in a pivotal Phase 3 clinical trial evaluating its lead cancer therapeutic, pegylated arginine deiminase (ADI-PEG 20), in hepatocellular carcinoma (HCC) patients.” View full resource at news-medical.net
Most Recently Shared on July 29, 2011 at 8:19 am By:
Lung Cancer News: Polaris initiates ADI-PEG 20 Phase 3 trial in hepatocellular carcinoma: Polaris Group today an... http://bit.ly/nAN1aV
Mayo Clinic trial to evaluate folate receptor alpha-targeted breast/ovarian cancer vaccine
news-medical.net — “VaxOnco, a leading oncology biopharmaceutical company, today announced that following FDA IND approval, it will sponsor a Phase I folate receptor alpha-targeted therapeutic vaccine clinical trial in disease-free patients, previously diagnosed with either breast or ovarian cancer at Mayo Clinic.” View full resource at news-medical.net
Most Recently Shared on July 25, 2011 at 1:40 pm By:
News-Medical.Net Oncology and Health News
Oncology News: Mayo Clinic trial to evaluate folate receptor alpha-targeted breast/ovarian cancer vaccine: VaxOn... http://bit.ly/nMvEND
Prostate Cancer Drug Zytiga Extends Life; UK, Europe to Approve | Suite101.com
suite101.com — “In clinical trials Zytiga has shown to extend the lives of aggressive prostate cancer patients on average by four months. Its use in Europe is near.” View full resource at suite101.com
Most Recently Shared on July 23, 2011 at 6:08 pm By:
Prostate Cancer Drug Zytiga Extends Life; UK, Europe to Approve: In clinical trials Zytiga has shown to extend t... http://bit.ly/n16B8p
23 Patients With Organ Confined Low Risk Prostate Cancer Have Been Treated In Clinical Trials Using The ExAblate(R) Non-Invasive Prostate System
medicalnewstoday.com — “InSightec Ltd., the global leader in MR-guided focused ultrasound technology and the only company to receive FDA approval for its ExAblate® system for treating uterine fibroids, announced toda” View full resource at medicalnewstoday.com
Most Recently Shared on July 14, 2011 at 9:38 am By:
Drugs and Devices OW OW Health
23 Patients With Organ Confined Low Risk Prostate Cancer Have Been Treated In Clinical Trials Using T... http://bit.ly/oxnrif #MedDevice
Advertisement
